Article info
PDFShort report
Expression of high-molecular-weight cytokeratin (34βE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast
- Correspondence to Dr Erika Resetkova, Department of Pathology and Laboratory Medicine, Box 85, The University of Texas M. D. Anderson Cancer Center, Holcombe Boulevard, Houston, TX 77030, USA; eresetko{at}mdanderson.org
Citation
Expression of high-molecular-weight cytokeratin (34βE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast
Publication history
- Accepted May 25, 2010
- First published August 11, 2010.
Online issue publication
August 10, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.